Funding
This study (NCT03386955) was funded by Beta Pharma (Shanghai) Co., Ltd, Shanghai, People’s Republic of China, partly supported by the New National Natural Science Foundation of China (82172856, 81972805) and the China National Major Project for New Drug Innovation (2017ZX09304015).